(Q36989599)

English

A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone

scientific article published on 07 April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

multicenter clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

John W Newcomer

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Robert E Ratner

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Jan W Eriksson

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Robin Emsley

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Didier Meulien

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Frank Miller

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Julia Leonova-Edlund

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Ronald W Leong

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Martin Brecher

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

7 April 2009

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

The Journal of Clinical Psychiatry

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

70

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

487-499

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

Standards of medical care in diabetes--2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

The metabolic effects of antipsychotic medications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

The Canadian Diabetes Association guidelines: putting the evidence first

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

Abnormalities of glucose metabolism associated with atypical antipsychotic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

STUDIES ON THE HYPERGLYCAEMIA INDUCED BY CHLORPROMAZINE IN RATS

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

9 September 2017

Severe mental illness and risk of cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

4 September 2018

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

4 September 2018

Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

4 September 2018

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

4 September 2018

Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

4 September 2018

Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

4 September 2018

A model-based method for assessing insulin sensitivity from the oral glucose tolerance test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

4 September 2018

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

4 September 2018

Prevalence and correlates of diabetes in national schizophrenia samples.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

4 September 2018

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3703648

4 September 2018

Adiposity and insulin sensitivity derived from intravenous glucose tolerance tests in antipsychotic-treated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19358783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36989599&oldid=1566651414"